HB

Haresh Bachubhai Chudasama

Active Director Director DIN 11239177
DIN 11239177 First appointment Aug 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Haresh Bachubhai Chudasama

Data last updated:

Haresh Bachubhai Chudasama is a Director at Jorvedis Pharma Private Limited (since 2025).

DIN 11239177
Primary Designation Director
First Appointment 12 Aug 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jorvedis Pharma Private Limited U21000GJ2025PTC166144
Director12 Aug 20252025Active

Directorship timeline

Open interactive timeline →
Jorvedis Pharma Private Limited
Premium access

Shareholding and investment profile for Haresh Bachubhai Chudasama

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Haresh Bachubhai Chudasama

Haresh Bachubhai Chudasama currently holds 1 directorship: Jorvedis Pharma Private Limited (Director, since 12 Aug 2025).

Haresh Bachubhai Chudasama was first appointed on 12 Aug 2025 as Director at Jorvedis Pharma Private Limited.

The current boards of Haresh Bachubhai Chudasama's companies include Chamanlal Mohanlal Bhanvadia (Jorvedis Pharma Private Limited), Patel Minakshiben (Jorvedis Pharma Private Limited), Rajesh Vinodkumar Ghanshani (Jorvedis Pharma Private Limited), Ronakkumar Mahendrabhai Patel (Jorvedis Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available